Matinas BioPharma ( (MTNB) ) just unveiled an announcement.
On March 13, 2025, Eric Ende announced his resignation from the Board of Directors and as Chairman of Matinas BioPharma, effective March 14, 2025, due to other professional commitments. His departure was not due to any disagreement or shift in the company’s direction, indicating stability in the company’s strategic focus and operations.
More about Matinas BioPharma
Matinas BioPharma is a company operating in the biopharmaceutical industry, focusing on the development of innovative therapies and products.
YTD Price Performance: -10.51%
Average Trading Volume: 469,999
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $2.72M
See more insights into MTNB stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com